Where vitamin K2 MK-7 is permitted, and what the file must show
Permission for vitamin K2 MK-7 depends on the market, the source and the form, not on the name alone. In the EU the ingredient sits on the novel-food Union list, with a specification written around menaquinone-7; in the US it is sold as a dietary ingredient; in the UK the retained novel-food list has to be checked separately. The file has to connect the form, the specification, the label and the claim for the market where the product is sold.
Permission attaches to the form and the source, not to the words vitamin K2 on the label.
Four checks, not one
A compliance file is often treated as a single certificate. It is at least four checks. First, is the form and source permitted in the market? Second, does the lot meet the specification that the permission refers to? Third, does the label use the permitted name, units and declarations? Fourth, is the claim on the pack one that the market allows for this ingredient? A file that answers only the second question is a laboratory file, not a market file.
The four checks can fail independently: a compliant lot can carry a non-compliant label, and a permitted claim can be attached to the wrong form. The sections below take each check in turn.
The EU novel-food entry
Regulation (EU) 2017/2470 establishes the Union list of novel foods. The entry for vitamin K2 (menaquinone) covers a product made by a synthetic or a microbiological process. The specification for the synthetic route describes 97–102% menaquinone-7, including at least 92% all-trans, with no more than 6.0% cis isomers and no more than 2.0% other impurities. The microbiological route names a Bacillus source, including Bacillus subtilis ssp. natto, and carries its own specification.
The entry also sets the labelling designation: "Menaquinone" or "Vitamin K2". Use in food supplements is directed to the food-supplement framework, including Directive 2002/46/EC, Regulation (EU) No 609/2013 and Regulation (EC) No 1925/2006, and the conditions in the entry apply. Read the current consolidated text before relying on a summary, because the annex is amended and the source route matters.
A 1% spray-dried powder is a formulation of the authorised MK-7 on a starch or gum arabic matrix, not a different menaquinone. The MK-7 in the powder has to meet the entry's specification, and the carrier has to be a permitted food ingredient, declared on the label. The dilution does not lower the specification the MK-7 has to meet.
The US dietary-ingredient route
In the United States, MK-7 is sold as a dietary ingredient under DSHEA. The supplier should be able to say whether the ingredient was marketed as a dietary ingredient before 15 October 1994 or is supported by a new dietary ingredient notification. A GRAS notice for a conventional food use is a different route from a dietary-supplement ingredient; it does not substitute for the dietary-ingredient basis.
The finished product is made under the dietary-supplement cGMPs in 21 CFR 111, and the Supplement Facts panel follows 21 CFR 101.36. Vitamin K is declared in micrograms, with the source named in parentheses. A structure/function statement needs the DSHEA disclaimer and must not be a disease claim. The file should include the ingredient basis, the specification and the certificate, not only a "food grade" statement.
The UK retained list
Great Britain maintains its own retained version of the novel-food list, held by the Food Standards Agency. It started from the EU list but can diverge as each side amends its text. Check the current GB list for the MK-7 entry, the source route and the specification before shipping. Northern Ireland applies EU rules under the Windsor Framework, so a GB-only check is not enough for a product placed in Belfast or sold cross-border.
The UK label also has its own requirements for the food-supplement declaration and the vitamin K contribution. The practical rule is the same as in the EU: the form and the source have to match the list entry, and the label has to use the permitted designation.
The limits in the file
| Parameter | Catalog limit | What the file should show |
|---|---|---|
| Heavy metals | Pb ≤3 · As ≤2 · Cd ≤1 · Hg ≤0.1 mg/kg | ICP-MS results against the market's contaminant ceilings |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Method and result for each test |
| Loss on drying | ≤5.0% | Result and basis |
| Particle size | ≥95% through 40 mesh | Sieve method and result |
These are catalog release limits, not a statement that every market applies the same legal maximum. Contaminant ceilings are set by the destination market and can be tighter for a particular food category. The certificate should show the measured result; the file should map it to the ceiling for the product being sold.
Where the claim boundary sits
In the EU, nutrition and health claims are governed by Regulation (EC) No 1924/2006 and the EU Register of nutrition and health claims. A claim may be used only if it is on the Register, matches the conditions of use and is not a disease claim. Vitamin K has authorised claims, but this page does not reproduce or rely on any of them; the brand's own regulatory review decides whether a claim is available for its product and dose.
The ingredient name is not a claim: "MK-7" and "all-trans" are specification terms, not permitted health claims. In the US, a structure/function statement needs the DSHEA disclaimer and must not make a disease claim. The UK has its own register and enforcement; a claim authorised in the EU is not automatically available in Great Britain.
The document set
| Document | What it should establish |
|---|---|
| Certificate of analysis | Lot code, MK-7 content, all-trans ratio, carrier, contaminants, micro |
| Technical data sheet | Grade, carrier, solubility, particle size, pack and storage |
| Safety data sheet | Handling, transport and storage classification |
| Specification | The release limits the certificate is judged against |
| Allergen and GMO statements | Carrier source and any declaration the market requires |
| Source statement | Synthetic or microbiological route, and the manufacturing site |
| Novel-food statement | How the ingredient maps to the EU or GB list entry |
A short checklist
- Does the certificate name the lot, the grade and the carrier?
- Does the MK-7 result meet the specification on the stated basis?
- Is the all-trans figure reported separately from the total MK-7?
- Does the label use the market's permitted designation and units?
- Is the carrier declared in the ingredient list?
- Is every claim on the pack permitted for this form and this market?
- Does the source statement match the list entry the file relies on?
- Do the COA, pack label and retained sample share one lot code?
The product specification is on the vitamin K2 MK-7 product page. The certificate is explained on the COA page; the grade and carrier on the grade page; the identity evidence on the identity page. Market notes are kept in the EU, US and UK regulatory pages, and the release workflow is on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation